SCHEMBL6530247

SCHEMBL6530247

COc1ccc(CCNc2nc(Nc3cccc(F)c3)nc(N[C@@H](CC(C)C)C(=O)O)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CTSK P43235 2/20 0.44
CNR2 P34972 4/20 0.43
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
CA14 Q9ULX7 2/20 0.42
KCNH3 Q9ULD8 3/20 0.41
PTGDR Q13258 1/20 0.40
FCGR3B O75015 1/20 0.40
FCGR1A P12314 1/20 0.40
FCGR2A P12318 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6530423 0.93 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6530426 0.93 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6531002 0.87 ALDH1A1 (0.49) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6529116 0.87 CA1 (0.60) ALDH1A1CA12CA1CA2CA9
SCHEMBL6529110 0.87 CA1 (0.60) ALDH1A1CA12CA1CA2CA9
SCHEMBL6528931 0.84 KCNH3 (0.41) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6529735 0.82 CA1 (0.52) ALDH1A1CA12CA1CA2CA9
SCHEMBL6529732 0.82 CA1 (0.52) ALDH1A1CA12CA1CA2CA9
SCHEMBL8298689 0.81 CYP2C9 (0.44) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6528805 0.81 CYP2C9 (0.44) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed